Narendra Modi's Washington test

Narendra Modi's Washington test

If Modi gets the world’s biggest power right, his pursuit of larger global goals...
Small banks or banks for ‘small’ people?

Small banks or banks for ‘small’ people?

Unless appropriate sub-limits are imposed on loans, there is a serious...

India's Natco Pharma surges on favourable US court ruling for Teva Pharmaceutical Industries

Nov 14 2013, 15:26 IST
Comments 0
Shares in India's Natco Pharma Ltd surge 6 percent after prospects for its generic version for Teva Pharmaceutical Industries' billion dollar drug got a boost from a favourable US court ruling. Reuters Shares in India's Natco Pharma Ltd surge 6 percent after prospects for its generic version for Teva Pharmaceutical Industries' billion dollar drug got a boost from a favourable US court ruling. Reuters
SummaryShares in Natco Pharma surge 6 pct after prospects for its generic version for Teva Pharmaceutical Industries.

Shares in India's Natco Pharma Ltd surge 6 percent after prospects for its generic version for Teva Pharmaceutical Industries' billion dollar drug got a boost from a favourable US court ruling on Wednesday.

An US Supreme Court justice on Wednesday declined a request from Teva for a stay of an appeals court ruling that would strip the company's $4 billion-a-year multiple sclerosis drug Copaxone of patent protection in 2014, rather than in 2015.

In July, the US Court of Appeals for the Federal Circuit issued a decision in a patent fight that pits Teva against two teams developing cheaper generic forms of Copaxone: one with Novartis AG and Momenta Pharmaceuticals Inc ; and another between Mylan Inc and Natco Pharma.

Ads by Google
Reader´s Comments
| Post a Comment
Please Wait while comments are loading...